SIMM(Shanghai Institute of Materia Medica) and WIV（Wuhan Institute of Virology）’s joint research released preliminary findings, that the Chinese medicine Shuang-Huang-Lian oral liquid can inhibit the new coronavirus. Previously,Shanghai Institute of Materia Medica had formed an emergency to study the new coronavirus led by Professor Jiang Hualiang, Based the early SARS-related research and drug discovery results, the team focused on the virus treatment candidate, new drug screening, evaluation and new use of old drugs research.
Shuang-Huang-Lian oral liquid is comprised of Japanese honeysuckle, Chinese skullcap, Forsythia suspensa, three Chinese medicine composition. Traditional Chinese medicine believes that these three Chinese medicine has the role of detoxifying heat . Modern medical research holds that Shuang-Huang-Lian oral liquid has the function of broad-spectrum antiviral, anti-bacterial, and improve the immune function of the body, and is one of the effective broad-spectrum antiviral drugs.
Shanghai Institute of Materia Medica has long been engaged in antiviral drug research, in 2003 “SARS” period, Shanghai Institute of Materia Medica zuo Jianping team was the first to confirm that Shuang-Huang-Lian oral liquid has anti-SARS coronavirus effect, in the past ten years , they confirmed that Shuang-Huang-Lian oral liquid has obvious antiviral effects to influenza virus (H7N9, H1N1, H5N1), Severe acute respiratory syndrome coronavirus, MERS coronavirus .
At present, Shanghai Public Health Clinical Center and Tongji Hospital has started clinical research on Shuang-Huang-Lian oral liquid.